Inovalon Investor Presentation
May, 2019

Press Release

Inovalon Data Powers New Insights on Diverse Healthcare Populations

March 28, 2019 at 7:55 AM EDT

Data-Driven Research Presented at Academy of Managed Care Pharmacy (AMCP) and ISPOR Annual Meetings Powered by Inovalon’s MORE2 Registry®Dataset

BOWIE, Md., March 28, 2019 (GLOBE NEWSWIRE) -- Inovalon (Nasdaq: INOV), a leading technology company providing advanced, cloud-based platforms empowering data-driven healthcare, today announced new research to be presented across all major healthcare coverage populations powered by its large-scale, real-world Medical Outcomes Research for Effectiveness and Economics Registry (MORE2 Registry®).

Data from Inovalon’s MORE2 Registry®, one of the nation’s largest and most comprehensive healthcare datasets, will be featured in research presented at the Academy of Managed Care Pharmacy (AMCP) Managed Care & Specialty Pharmacy Annual Meeting and the upcoming International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Meeting.

“The results being presented highlight the real challenges that health plans and providers have in serving diverse healthcare populations,” said John E. Linnehan, director of the Health Economics & Advanced Analytics practice at Avalere Health, an Inovalon company. “The challenges and opportunities identified in these studies will support targeted initiatives to improve quality outcomes for patients, and the success of our clients working to serve them.”

Inovalon’s MORE2 Registry® dataset is one of the nation’s largest primary source, longitudinally matched datasets containing real-world medical, pharmacy, laboratory, demographic, and clinical data on more than 264 million unique patients and 42 billion medical events across Medicare fee-for-service, Medicare Part D, Medicare Advantage, managed Medicaid, and commercially insured populations. Ongoing analysis of the MORE2 Registry® dataset powers highly valuable insights into important healthcare issues; machine learning, deep learning, and artificial intelligence algorithm development and training for Modules of the Inovalon ONE® Platform; and the real-time decision support, care, quality, outcomes and economic improvements of healthcare empowered through Inovalon’s solutions.

This research, spanning multiple high-impact healthcare industry challenges, was conducted by Avalere Health, an Inovalon company specializing in data-driven healthcare research and strategic advisory services, in partnership with its clients.

Research to be presented:

Academy of Managed Care Pharmacy (AMCP) Managed Care & Specialty Pharmacy Annual Meeting on March 25-28, 2019 in San Diego, CA

  • Comparison of Healthcare Utilization Among Managed Medicaid Individuals Diagnosed with Multiple Sclerosis Treated with Emergent vs. Established Disease Modifying Therapy in the US
  • The Impact of Abuse Deterrent Formulation Opioid Utilization on Healthcare Resource Use Among Managed Medicaid Patients

International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Meeting on May 18-22, 2019 in New Orleans, LA

  • Comparing Utilization, Cost and Quality in Dual Eligible Medicare Advantage and Fee-For-Service Medicare Beneficiaries
  • Differences Between Enrollees of Individual Versus Small Group Off-Exchange Health Plans Under the Affordable Care Act
  • Risk Adjusting Medicare Advantage Plan Performance Measures for Social Determinants of Health: Are Dual Eligibility and Disability Status Enough?
  • Leveraging Data-Driven Insights to Support Development of Targeted Supplemental Benefits Under Newly Expanded Flexibilities in Medicare Advantage to Improve Outcomes in High-Cost, High-Need Beneficiaries
  • Predicting Falls in Elderly Patients Using Claims Data: A Time-Awarded Deep Learning Approach
  • Healthcare Resource Utilization & Expenditures among Medicare Beneficiaries Newly Diagnosed with Peripheral T-cell Lymphoma (PTCL): A Retrospective Claims Analysis

About Inovalon

Inovalon is a leading technology company providing cloud-based platforms empowering data-driven healthcare. Through the Inovalon ONE® Platform, Inovalon brings to the marketplace a national-scale capability to interconnect with the healthcare ecosystem, aggregate and analyze data in real-time, and empower the application of resulting insights to drive meaningful impact at the point of care. Leveraging its platform, unparalleled proprietary data sets, and industry-leading subject matter expertise, Inovalon enables better care, efficiency, and financial performance across the healthcare ecosystem. From health plans and provider organizations, to pharmaceutical, medical device, and diagnostics companies, Inovalon's unique achievement of value is delivered through the effective progression of “Turning Data into Insight, and Insight into Action®.” Supporting thousands of clients, including 24 of the top 25 U.S. health plans and 22 of the top 25 global pharma companies, Inovalon's technology platforms and analytics are informed by data pertaining to more than 964,000 physicians, 519,000 clinical facilities, 264 million Americans, and 42 billion medical events. For more information, visit www.inovalon.com.

Contact:

Inovalon
Kim E. Collins
Phone: 301-809-4000 x1473
kcollins@inovalon.com

New INOV Logo_6.22.16.jpg

Source: Inovalon Holdings, Inc.

© 2018 Inovalon. All rights reserved.